临床试验设备及支援解决方案市场－全球产业规模、份额、趋势、机会及预测（依产品、阶段、地区及竞争格局划分，2021-2031年）

全球临床试验设备及相关解决方案市场预计将从 2025 年的 40.5 亿美元成长到 2031 年的 65.2 亿美元，复合年增长率为 8.26%。

此领域涵盖关键医疗设备、低温运输储存基础设施以及合规高效进行研究所需的物流服务。推动这一领域扩张的主要因素是全球临床研究数量的成长以及研究通讯协定日益复杂，这需要专业的供应链管理。药物开发平臺的活跃度活性化也印证了这一上升趋势。例如，英国製药工业协会 (ABPI) 报告称，到 2024 年，英国启动的新临床试验数量将比上一年增加 35.7%。这些因素凸显了对可靠的设备采购和管理策略日益增长的需求，以促进药物研发的加速发展。

然而，这种积极势头面临严峻挑战，因为跨境引进设备需要满足复杂的监管合规要求。管理全球各地不同的设备校准和进口标准往往会造成严重的物流瓶颈，导致研究启动延迟和营运成本增加。因此，这些严格的监管障碍可能会阻碍辅助解决方案供应商顺利拓展全球业务，从而影响其为跨国临床试验中心提供支援。

市场驱动因素

药品和生技製药研发成本的不断攀升是推动临床试验设备及辅助解决方案市场发展的主要动力。随着製药公司投入大量研发新治疗方法，对专用医疗设备和物流基础设施的投资也同步成长。这笔资金的涌入确保了试验中心拥有必要的精密设备和储存能力，以保障研究的完整性。例如，欧洲製药工业协会联合会（EFPIA）在2024年11月估计，欧洲以研发为基础的製药业当年在研发方面的投资约为550亿欧元。这笔巨额资金直接用于辅助用品的采购，并确保复杂的生物样本和临床实验药品得到严格遵守安全标准的管理。

此外，全球临床试验数量的不断增长推动了对可扩展支援解决方案和设备管理服务的需求。随着平行研究的日益增多，稳健的供应链对于防止瓶颈并确保所有研究中心（无论其位于何处）都能及时获得所需材料至关重要。 2025年4月，美国国立卫生研究院 (NIH) 宣布，截至2024年，在ClinicalTrials.gov网站上註册的研究数量累计已超过50万项。这一增长已超越了传统的西方中心，涵盖了众多地区，因此需要针对每个地区制定相应的物流策略。欧洲生物技术杂誌2025年的报告指出，中国临床试验註册中心在2024年记录了约4900项临床试验，这凸显了支持广泛的国际研究活动对设备解决方案日益增长的需求。

市场挑战

全球临床试验设备及辅助解决方案市场面临的一大障碍是跨境设备部署所需的复杂监管合规要求。随着临床试验越来越多地跨越多个国家以覆盖不同的患者群体，供应商不得不应对设备进口和校准方面国际标准的碎片化。这种监管复杂性造成了严重的物流瓶颈，常常导致关键医疗设备和辅助用品的清关延误，或需要获得特定地区的认证才能在研究中心合法使用。

这些延误直接影响研究进度的效率，并限制了市场在全球快速扩张的潜力。当辅助解决方案未能顺利实施时，研究启动将被推迟，这给依赖严格时间表的製药申办者造成了巨大的营运阻力。近期行业数据也印证了这项影响。根据临床研究机构协会 (SCRS) 预测，到 2024 年，全球 35% 的临床临床实验中心将把研究启动流程列为一项主要的营运挑战。这项统计数据凸显了物流和监管方面的障碍（例如合规设备采购方面的障碍）如何显着延迟研究启动，从而限制了整个辅助解决方案市场的成长和流动性。

市场趋势

随着申办方越来越多地利用远端监测工具来提高患者参与度和保留率，分散式临床试验 (DCT) 设备的快速普及正在重塑市场格局。这一趋势推动了以患者为中心的辅助解决方案（例如可穿戴感测器和家庭健康套件）需求的激增，这些解决方案能够在传统医疗机构之外收集数据。此模式在涵盖代表性不足人群方面的有效性是其主要驱动因素。例如，塔夫茨药物研发研究中心 (Tufts Center for the Study of Drug Development) 于 2025 年 1 月报告称，分散式试验中亚裔参与者的比例已增至 20.9%，与传统医疗机构研究中的 14.2% 相比，这是一个显着的进步。因此，供应商正在转型，提供轻鬆的远端设备，以支援这些以多元化为重点的招募策略。

同时，在全产业积极推动永续性目标的推动下，环保且可重复使用的包装解决方案备受关注。相关人员正迅速以循环物流模式取代一次性保温包装，以减少碳足迹并最大限度地减少临床供应链中的废弃物。这种营运模式的转变也体现在主要低温运输供应商的策略中，他们正在扩大可重复使用资产的规模，以最大限度地提高库存利用率。根据 Envirotainer 公司 2025 年 4 月发布的《永续发展报告》，该公司 75% 的货物运输采用单程租赁方式，其中 71% 的货柜透过订单退回，从而避免空箱运输。这项转变凸显了一种永久性的结构性变化，即环境因素日益成为采购决策中配套运输解决方案的主要驱动力。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球临床试验设备及支援解决方案市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（采购（购买/租赁）、供应/物流、服务、其他）
  • 依阶段（第一阶段、第二阶段、第三阶段、第四阶段）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美临床试验设备及配套解决方案市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲临床试验设备及配套解决方案市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区临床试验设备及配套解决方案市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲临床试验设备及配套解决方案市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲临床试验设备及配套解决方案市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球临床试验设备及辅助解决方案市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Ancillare, LP
• Imperial Clinical Research Services Inc
• Woodley Equipment Company Ltd
• Thermo Fisher Scientific Inc
• PAREXEL International Corp
• Emsere
• Quipment SAS
• Marken Ltd.
• Myonex
• Yourway

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Clinical Trial Equipment and Ancillary Solutions Market for is projected to experience significant growth, increasing from USD 4.05 billion in 2025 to USD 6.52 billion by 2031, representing a CAGR of 8.26%. This sector includes critical medical devices, cold chain storage infrastructure, and logistics services necessary for conducting compliant and effective research studies. The primary drivers of this expansion are the rising global volume of clinical research and the growing complexity of study protocols, which require specialized supply chain management. This upward trend is demonstrated by heightened activity within pharmaceutical development pipelines; for instance, the Association of the British Pharmaceutical Industry reported a 35.7% increase in new clinical trial initiations in the UK in 2024 compared to the prior year. These factors emphasize the increasing need for reliable equipment procurement and management strategies to facilitate faster drug development.

However, this positive momentum faces substantial challenges due to the complex regulatory compliance required for deploying equipment across international borders. Managing diverse global standards for device calibration and importation often causes significant logistical bottlenecks that can delay study start times and escalate operational costs. Consequently, these strict regulatory barriers may hinder the smooth global expansion of ancillary solution providers as they endeavor to support multinational clinical trial sites.

Market Driver

Rising expenditures in pharmaceutical and biopharmaceutical research and development are serving as a major catalyst for the clinical trial equipment and ancillary solutions market. As drug developers dedicate significant capital to discovering novel therapies, there is a parallel increase in investment for specialized medical devices and logistical infrastructure. This financial influx ensures that trial sites possess the necessary precision instruments and storage capabilities to uphold study integrity. For example, the European Federation of Pharmaceutical Industries and Associations estimated in November 2024 that the research-based pharmaceutical industry in Europe invested approximately €55,000 million in R&D during that year. This massive capital injection directly supports the procurement of ancillary supplies, ensuring that complex biological samples and investigational products are managed in strict accordance with safety standards.

Additionally, the global proliferation of clinical trial volumes amplifies the demand for scalable ancillary solutions and equipment management services. As the frequency of concurrent studies rises, a robust supply chain is essential to prevent bottlenecks and ensure timely access to materials for all sites, regardless of location. The National Institutes of Health noted in April 2025 that the cumulative number of studies registered on ClinicalTrials.gov exceeded 500,000 in 2024. This expanding volume extends beyond traditional Western centers to include diverse regions requiring tailored logistical strategies; European Biotechnology reported in 2025 that the Chinese registry recorded approximately 4,900 clinical studies for 2024, highlighting the growing necessity for equipment solutions capable of supporting extensive international research operations.

Market Challenge

The primary obstacle hindering the Global Clinical Trial Equipment & Ancillary Solutions Market is the complex regulatory compliance required for deploying equipment across borders. As clinical trials increasingly span multiple countries to access diverse patient populations, vendors are forced to navigate a fragmented landscape of international standards regarding device importation and calibration. This regulatory complexity creates severe logistical bottlenecks, as essential medical devices and ancillary supplies frequently face prolonged detention at customs or require region-specific certification before they can be legally used at trial sites.

These delays directly compromise the efficiency of research timelines, limiting the market's potential for rapid global expansion. When ancillary solutions cannot be deployed seamlessly, trial initiation is postponed, causing substantial operational friction for pharmaceutical sponsors who depend on strict schedules. This impact is supported by recent industry data; according to the Society for Clinical Research Sites, in 2024, 35% of global investigative sites identified study start-up processes as a leading operational challenge. This statistic underscores how logistical and regulatory hurdles, such as those involved in compliant equipment procurement, critically stall the commencement of research, thereby restricting the overall growth and fluidity of the ancillary solutions market.

Market Trends

The market is being reshaped by the accelerated adoption of decentralized clinical trial (DCT) equipment, as sponsors increasingly utilize remote monitoring tools to improve patient inclusivity and retention. This trend is fueling a surge in demand for patient-centric ancillary solutions, such as wearable sensors and home-health kits, which facilitate data collection outside of traditional site settings. The effectiveness of this model in reaching underrepresented populations is a significant driver; for instance, the Tufts Center for the Study of Drug Development reported in January 2025 that decentralized trials increased Asian participant representation to 20.9%, compared to just 14.2% in traditional site-based studies. Consequently, equipment vendors are pivoting to provide lightweight, user-friendly remote devices that support these diversity-focused recruitment strategies.

Concurrently, there is a strong emphasis on eco-friendly and reusable packaging solutions, driven by aggressive industry-wide sustainability goals. Stakeholders are swiftly replacing single-use thermal packaging with circular logistics models to lower carbon footprints and minimize waste within the clinical supply chain. This operational shift is evident in the strategies of major cold chain providers who are expanding their pools of reusable assets to maximize inventory utility. Envirotainer's April 2025 sustainability report noted that 75% of its shipments utilized one-way leases, with 71% of these units returned via orders to avoid empty container movements. This transition highlights a permanent structural change wherein environmental stewardship increasingly dictates procurement decisions for ancillary shipping solutions.

Key Market Players

• Ancillare, LP
• Imperial Clinical Research Services Inc
• Woodley Equipment Company Ltd
• Thermo Fisher Scientific Inc
• PAREXEL International Corp
• Emsere
• Quipment SAS
• Marken Ltd.
• Myonex
• Yourway

Report Scope

In this report, the Global Clinical Trial Equipment & Ancillary Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Trial Equipment & Ancillary Solutions Market, By Product

• Sourcing (Procurement, Rental)
• Supply/Logistics
• Service
• Others

Clinical Trial Equipment & Ancillary Solutions Market, By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trial Equipment & Ancillary Solutions Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clinical Trial Equipment & Ancillary Solutions Market.

Available Customizations:

Global Clinical Trial Equipment & Ancillary Solutions Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clinical Trial Equipment & Ancillary Solutions Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Sourcing (Procurement, Rental), Supply/Logistics, Service, Others)
  • 5.2.2. By Phase (Phase I, Phase II, Phase III, Phase IV)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Clinical Trial Equipment & Ancillary Solutions Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Phase
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Phase
  • 6.3.2. Canada Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Phase
  • 6.3.3. Mexico Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Phase

7. Europe Clinical Trial Equipment & Ancillary Solutions Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Phase
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Phase
  • 7.3.2. France Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Phase
  • 7.3.3. United Kingdom Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Phase
  • 7.3.4. Italy Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Phase
  • 7.3.5. Spain Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Phase

8. Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Phase
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Phase
  • 8.3.2. India Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Phase
  • 8.3.3. Japan Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Phase
  • 8.3.4. South Korea Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Phase
  • 8.3.5. Australia Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Phase

9. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Phase
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Phase
  • 9.3.2. UAE Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Phase
  • 9.3.3. South Africa Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Phase

10. South America Clinical Trial Equipment & Ancillary Solutions Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Phase
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Phase
  • 10.3.2. Colombia Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Phase
  • 10.3.3. Argentina Clinical Trial Equipment & Ancillary Solutions Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Phase

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Clinical Trial Equipment & Ancillary Solutions Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Ancillare, LP
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Imperial Clinical Research Services Inc
• 15.3. Woodley Equipment Company Ltd
• 15.4. Thermo Fisher Scientific Inc
• 15.5. PAREXEL International Corp
• 15.6. Emsere
• 15.7. Quipment SAS
• 15.8. Marken Ltd.
• 15.9. Myonex
• 15.10. Yourway

16. Strategic Recommendations

17. About Us & Disclaimer